Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma
The immunohistochemically assessed IS might be a useful prognostic marker for patients with PDAC who underwent primary tumor resection.
Authors
- Hiromitsu Maehira (ORCID: https://orcid.org/0000-0003-3064-5216)
- Masanori Shiohara
- Toru Miyake (ORCID: https://orcid.org/0000-0003-0947-0116)
- Haruki Mori (ORCID: https://orcid.org/0000-0001-9143-256X)
- Masaji Tani (ORCID: https://orcid.org/0000-0003-1270-6003)
- Hiroya Iida (ORCID: https://orcid.org/0000-0001-6245-4583)
- Nobuhito Nitta
Institutions
- Shiga University of Medical Science (JP)
- Shiga University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.21873/anticanres.17277
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.57